Clinical Psychopharmacology · Paper A
Switching antidepressants
Switching between antidepressants requires a different strategy depending on the two drugs involved, the exam tests whether you pick a direct switch, a cross-taper, or a full washout. Switching between two similar short-half-lifeThe time it takes for the amount of a drug in the body to fall by half.Read more → SSRIs (selective serotonin reuptake inhibitors) with a direct switch (stopping one and starting the other the next day) is usually fine. Switching to or from an irreversible MAOIMonoamine oxidase inhibitor, an older antidepressant with strict food and drug interaction rules.Read more → (monoamine oxidase inhibitor) needs a full washout instead, because combining them risks serotonin syndromeA dangerous reaction from too much serotonin activity, causing agitation, high temperature, and muscle overactivity.Read more →. Always check guidance for the exact drug pair rather than applying one switching rule to every antidepressant.
A direct switch (stopping one drug and starting another the next day) suits similar short-half-lifeThe time it takes for the amount of a drug in the body to fall by half.Read more → agents. A cross-taper (reducing one while raising the other) is used more cautiously, and is avoided where interaction risk is high. Switching to or from an irreversible MAOIMonoamine oxidase inhibitor, an older antidepressant with strict food and drug interaction rules.Read more → (monoamine oxidase inhibitor) needs a 2-week washout, or 5 weeks after fluoxetine, given its long half-life, to avoid serotonin syndromeA dangerous reaction from too much serotonin activity, causing agitation, high temperature, and muscle overactivity.Read more →. Fluoxetine remains pharmacologically relevant long after its last dose (e.g. its active metaboliteA breakdown product of a drug that is itself still able to produce an effect in the body.Read more → lingers in the body for weeks) so its washout cannot be copied from a short-half-life SSRISelective serotonin reuptake inhibitor, a common type of antidepressant.Read more →. Clinically, the switching strategy is decided by the specific pharmacology of both drugs involved, not a single universal rule; exact intervals should be confirmed against the Maudsley switching tables rather than recalled from memory.
A fresh doctor might look for one universal "washout period" to memorise for every antidepressant switch. That single-number instinct is exactly what the exam punishes: the right strategy depends on which two drugs are involved and their shared risk of (a dangerous excess of activity) and discontinuation symptoms. Hold the phrase DEPENDS ON THE PAIR through every section below.
Switching antidepressants means moving a patient from one antidepressant to another, using one of three broad strategies: a direct switch (stop one, start the other the next day), a cross-taper (gradually reduce one while gradually increasing the other), or a washout (a drug-free interval between stopping one and starting the other). Which strategy applies is decided by the pharmacology of both drugs, especially their half-life (the time it takes drug levels to fall by half) and their risk of interacting.
A common mistake is memorising a single washout duration and applying it to every switch. The DEPENDS ON THE PAIR principle means the correct interval is a function of both drugs' half-lives and mechanisms, not a fixed number: the Maudsley Prescribing Guidelines switching tables exist specifically because this cannot be safely reduced to one rule, and an exact duration should always be confirmed against that source rather than recalled from memory.
Consider switching between two similar short- SSRIs (selective serotonin reuptake inhibitors): a direct switch is usually straightforward because neither drug lingers long enough to interact dangerously with the other. Now consider switching to or from an MAOI (monoamine oxidase inhibitor, an older antidepressant class that blocks the enzyme that breaks down serotonin, noradrenaline, and dopamine): combining an MAOI with a drug risks , a potentially fatal reaction, so a full washout period is mandatory rather than optional.
A direct switch suits agents with similar mechanisms and short half-lives, minimising the time a patient goes without treatment. A cross-taper allows a smoother transition but is used more cautiously, and avoided altogether where the interaction risk between the two drugs is high. A washout, a genuine drug-free interval, is reserved for higher-risk pairs, most importantly anything involving an , where any overlap risks .
Fluoxetine has an unusually long , and its (norfluoxetine, the compound the body converts fluoxetine into) stays pharmacologically active for weeks after the last dose. Because of this, switching from fluoxetine to an needs a longer washout than switching from most other antidepressants to an MAOI. A patient who stops fluoxetine and starts an MAOI too soon (for example, using the shorter interval that would suit a typical ) is still at real risk of because fluoxetine has not yet cleared.
Discontinuation symptoms (dizziness, flu-like symptoms, "electric shock" sensations) arise from stopping a drug too abruptly and should not be confused with , which arises from combining two drugs and presents with , , agitation, and fever. A cross-taper between two low-risk SSRIs is a routine, low-stakes switch and should not be treated with the same caution as any switch involving an .
is a clinical diagnosis, based on the constellation of (rhythmic muscle jerking), , agitation, tremor, and fever, since there is no single confirmatory blood test. The Hunter Serotonin Toxicity Criteria are the recognised clinical rule: in a patient who has taken a agent, spontaneous clonus, or inducible clonus plus agitation or sweating, or several similar combinations of these features, is enough to diagnose serotonin toxicity without waiting for any investigation. Recognising the timing matters too: serotonin syndrome typically comes on quickly after a specific drug change, whereas discontinuation symptoms build gradually as a previous drug's level falls, which is a useful bedside clue when the two are hard to separate.
Any switch involving an , or a switch away from a drug with a genuinely long like fluoxetine, should be checked against the Maudsley switching tables or BNF interaction guidance rather than recalled from memory, since prescribing the wrong interval risks on one side or a relapse-provoking treatment gap on the other. Patients should be counselled and screened for discontinuation symptoms during any taper and warned to seek urgent review if features of serotonin syndrome develop after a switch. If serotonin syndrome does occur, management is to stop the drugs immediately, provide supportive care (cooling, fluids, benzodiazepines for agitation), and seek urgent medical review, since severe cases can progress quickly.
Vignettes often describe a patient switched from fluoxetine to an after only the short gap typically used for other antidepressants, developing agitation, tremor, and : the expected recognition is from an inadequate washout, since fluoxetine needs a longer interval than most SSRIs. Another trap presents a straightforward switch between two similar SSRIs and expects candidates to recognise that a direct switch, not a cautious washout, is appropriate: over-caution is also a tested error.
The right strategy for switching antidepressants (direct switch, cross-taper, or washout) depends on the specific pair of drugs involved, not a single memorised rule, and MAOIs (plus long- drugs like fluoxetine) are the pairing that turns an ordinary switch into a genuine risk.